SensUs 2019, an international student competition at TU Eindhoven in which teams yearly compete with their own biosensor. This year they developed a biosensing system to detect precise levels of adalimumab in patients with rheumatoid arthritis.

credit: Bart van Overbeeke

SensUs 2019, an international student competition at TU Eindhoven in which teams yearly compete with their own biosensor. This year they developed a biosensing system to detect precise levels of adalimumab in patients with rheumatoid arthritis.

credit: Bart van Overbeeke

Na Coreia do Sul o governador Raimundo Colombo, o Deputado Jean Kuhlmann e demais representantes da comitiva catarinense, participam da reunião com a empresa SD Biosensor, que produz equipamentos para a área da saúde e pretende implantar uma unidade no Brasil que pode ser no RJ, PR ou SC. Na ocasião o governador e o secretário de Assuntos Internacionais, Alexandre Fernandes, obtiveram a confirmação de que os diretores dessa empresa visitarão Santa Catarina.

Foto: Rafael Wiethorn/SECOM

SensUs 2019, an international student competition at TU Eindhoven in which teams yearly compete with their own biosensor. This year they developed a biosensing system to detect precise levels of adalimumab in patients with rheumatoid arthritis.

credit: Bart van Overbeeke

A FRET-based biosensor monitors the activity of the calcium-activated protease calpain in a control cell (left) and a cell overexpressing the Golgi anti-apoptotic protein hGAAP (right). hGAAP enhances calpain activity (red) near the plasma membrane, thereby promoting focal adhesion turnover and cell migration.

Image courtesy of Saraiva et al.

Reference: Saraiva et al. (2013) J. Cell Biol. 202:699-713

Published on August 12, 2013.

doi: 10.1083/jcb.201301016

Read the full article online at: jcb.rupress.org/content/202/4/699.full

SensUs 2019, an international student competition at TU Eindhoven in which teams yearly compete with their own biosensor. This year they developed a biosensing system to detect precise levels of adalimumab in patients with rheumatoid arthritis.

credit: Bart van Overbeeke

SensUs 2019, an international student competition at TU Eindhoven in which teams yearly compete with their own biosensor. This year they developed a biosensing system to detect precise levels of adalimumab in patients with rheumatoid arthritis.

credit: Bart van Overbeeke

SensUs 2019, an international student competition at TU Eindhoven in which teams yearly compete with their own biosensor. This year they developed a biosensing system to detect precise levels of adalimumab in patients with rheumatoid arthritis.

credit: Bart van Overbeeke

Photos of Lab on a Chip Europe, Advances in Microarray Technology, Biodetection & Biosensors, Single Cell Analysis Europe, Barcelona 2013

SensUs 2019, an international student competition at TU Eindhoven in which teams yearly compete with their own biosensor. This year they developed a biosensing system to detect precise levels of adalimumab in patients with rheumatoid arthritis.

credit: Bart van Overbeeke

SensUs 2019, an international student competition at TU Eindhoven in which teams yearly compete with their own biosensor. This year they developed a biosensing system to detect precise levels of adalimumab in patients with rheumatoid arthritis.

credit: Bart van Overbeeke

SensUs 2019, an international student competition at TU Eindhoven in which teams yearly compete with their own biosensor. This year they developed a biosensing system to detect precise levels of adalimumab in patients with rheumatoid arthritis.

credit: Bart van Overbeeke

SensUs 2019, an international student competition at TU Eindhoven in which teams yearly compete with their own biosensor. This year they developed a biosensing system to detect precise levels of adalimumab in patients with rheumatoid arthritis.

credit: Bart van Overbeeke

SensUs 2019, an international student competition at TU Eindhoven in which teams yearly compete with their own biosensor. This year they developed a biosensing system to detect precise levels of adalimumab in patients with rheumatoid arthritis.

credit: Bart van Overbeeke

SensUs 2019, an international student competition at TU Eindhoven in which teams yearly compete with their own biosensor. This year they developed a biosensing system to detect precise levels of adalimumab in patients with rheumatoid arthritis.

credit: Bart van Overbeeke

Members of the biosensor team show components used in their new approach to lowering biomedical test costs. This immunosensor could be used for testing a variety of infectious diseases or other medical issues. August 24, 2009

Photos of Lab on a Chip Europe, Advances in Microarray Technology, Biodetection & Biosensors, Single Cell Analysis Europe, Barcelona 2013

Argonne researchers develop method that aims to stabilize antibodies

Researchers at Argonne National Laboratory have developed a systematic method to improve the stability of antibodies. The technique could lead to better biosensors, disease therapeutics, and non-laboratory applications, including environmental remediation. Read more »

Photo: Protein stability arises from networks of inter-atomic interaction. In this protein, a network is formed when Q37, a surface amino acid residue, forms a hydrogen bond with amino acid residue Y86 and interacts with amino acid residue D82 through a bridging water molecule.

Image by Raj Pokkuluri / Courtesy Argonne National Laboratory.

SensUs 2019, an international student competition at TU Eindhoven in which teams yearly compete with their own biosensor. This year they developed a biosensing system to detect precise levels of adalimumab in patients with rheumatoid arthritis.

credit: Bart van Overbeeke

SensUs 2019, an international student competition at TU Eindhoven in which teams yearly compete with their own biosensor. This year they developed a biosensing system to detect precise levels of adalimumab in patients with rheumatoid arthritis.

credit: Bart van Overbeeke

SensUs 2019, an international student competition at TU Eindhoven in which teams yearly compete with their own biosensor. This year they developed a biosensing system to detect precise levels of adalimumab in patients with rheumatoid arthritis.

credit: Bart van Overbeeke

SensUs 2019, an international student competition at TU Eindhoven in which teams yearly compete with their own biosensor. This year they developed a biosensing system to detect precise levels of adalimumab in patients with rheumatoid arthritis.

credit: Bart van Overbeeke

SensUs 2019, an international student competition at TU Eindhoven in which teams yearly compete with their own biosensor. This year they developed a biosensing system to detect precise levels of adalimumab in patients with rheumatoid arthritis.

credit: Bart van Overbeeke

SensUs 2019, an international student competition at TU Eindhoven in which teams yearly compete with their own biosensor. This year they developed a biosensing system to detect precise levels of adalimumab in patients with rheumatoid arthritis.

credit: Bart van Overbeeke

SensUs 2019, an international student competition at TU Eindhoven in which teams yearly compete with their own biosensor. This year they developed a biosensing system to detect precise levels of adalimumab in patients with rheumatoid arthritis.

credit: Bart van Overbeeke

SensUs 2019, an international student competition at TU Eindhoven in which teams yearly compete with their own biosensor. This year they developed a biosensing system to detect precise levels of adalimumab in patients with rheumatoid arthritis.

credit: Bart van Overbeeke

SensUs 2019, an international student competition at TU Eindhoven in which teams yearly compete with their own biosensor. This year they developed a biosensing system to detect precise levels of adalimumab in patients with rheumatoid arthritis.

credit: Bart van Overbeeke

SensUs 2019, an international student competition at TU Eindhoven in which teams yearly compete with their own biosensor. This year they developed a biosensing system to detect precise levels of adalimumab in patients with rheumatoid arthritis.

credit: Bart van Overbeeke

Bozena Kaminska, professor of engineering science, holds tiny diagnostic biosensors.

Kaminska is the winner of the B.C. Innovation Council's Entrepreneurship Fellow award in the 2010 BCIC-New Ventures competition.

SensUs 2019, an international student competition at TU Eindhoven in which teams yearly compete with their own biosensor. This year they developed a biosensing system to detect precise levels of adalimumab in patients with rheumatoid arthritis.

credit: Bart van Overbeeke

SensUs 2019, an international student competition at TU Eindhoven in which teams yearly compete with their own biosensor. This year they developed a biosensing system to detect precise levels of adalimumab in patients with rheumatoid arthritis.

credit: Bart van Overbeeke

SensUs 2019, an international student competition at TU Eindhoven in which teams yearly compete with their own biosensor. This year they developed a biosensing system to detect precise levels of adalimumab in patients with rheumatoid arthritis.

credit: Bart van Overbeeke

SensUs 2019, an international student competition at TU Eindhoven in which teams yearly compete with their own biosensor. This year they developed a biosensing system to detect precise levels of adalimumab in patients with rheumatoid arthritis.

credit: Bart van Overbeeke

SensUs 2019, an international student competition at TU Eindhoven in which teams yearly compete with their own biosensor. This year they developed a biosensing system to detect precise levels of adalimumab in patients with rheumatoid arthritis.

credit: Bart van Overbeeke

SensUs 2019, an international student competition at TU Eindhoven in which teams yearly compete with their own biosensor. This year they developed a biosensing system to detect precise levels of adalimumab in patients with rheumatoid arthritis.

credit: Bart van Overbeeke

SensUs 2019, an international student competition at TU Eindhoven in which teams yearly compete with their own biosensor. This year they developed a biosensing system to detect precise levels of adalimumab in patients with rheumatoid arthritis.

credit: Bart van Overbeeke

SensUs 2019, an international student competition at TU Eindhoven in which teams yearly compete with their own biosensor. This year they developed a biosensing system to detect precise levels of adalimumab in patients with rheumatoid arthritis.

credit: Bart van Overbeeke

SensUs 2019, an international student competition at TU Eindhoven in which teams yearly compete with their own biosensor. This year they developed a biosensing system to detect precise levels of adalimumab in patients with rheumatoid arthritis.

credit: Bart van Overbeeke

Photos of Lab on a Chip Europe, Advances in Microarray Technology, Biodetection & Biosensors, Single Cell Analysis Europe, Barcelona 2013

SensUs 2019, an international student competition at TU Eindhoven in which teams yearly compete with their own biosensor. This year they developed a biosensing system to detect precise levels of adalimumab in patients with rheumatoid arthritis.

credit: Bart van Overbeeke

Engineers have developed a tiny, ultra-low power chip that could be injected just under the surface of the skin for continuous, long-term alcohol monitoring. The chip is powered wirelessly by a wearable device such as a smartwatch or patch. The goal of this work is to develop a convenient, routine monitoring device for patients in substance abuse treatment programs.

Press release: jacobsschool.ucsd.edu/news/news_releases/release.sfe?id=2521

Photo credit: David Baillot/UC San Diego Jacobs School of Engineering

SensUs 2019, an international student competition at TU Eindhoven in which teams yearly compete with their own biosensor. This year they developed a biosensing system to detect precise levels of adalimumab in patients with rheumatoid arthritis.

credit: Bart van Overbeeke

SensUs 2019, an international student competition at TU Eindhoven in which teams yearly compete with their own biosensor. This year they developed a biosensing system to detect precise levels of adalimumab in patients with rheumatoid arthritis.

credit: Bart van Overbeeke

SensUs 2019, an international student competition at TU Eindhoven in which teams yearly compete with their own biosensor. This year they developed a biosensing system to detect precise levels of adalimumab in patients with rheumatoid arthritis.

credit: Bart van Overbeeke

SensUs 2019, an international student competition at TU Eindhoven in which teams yearly compete with their own biosensor. This year they developed a biosensing system to detect precise levels of adalimumab in patients with rheumatoid arthritis.

credit: Bart van Overbeeke